News | Heart Failure | April 21, 2023

Study Finds Equitable Heart Failure Care, but Challenges Remain

A new study finds hospitals in the American Heart Association’s Get With The Guidelines - Heart Failure program exhibit no disparities in heart failure care between Black and white patients

A new study finds hospitals in the American Heart Association’s Get With The Guidelines - Heart Failure program exhibit no disparities in heart failure care between Black and white patients

Human Chest Cavity illustration: Right lung, left lung, heart. Copyright American Heart Association 


April 21, 2023 — Black adults with heart failure (HF) are more likely to die than white adults with the same condition.[1] A new study published today in JAMA Cardiology that used the American Heart Association’s Get With The Guidelines - Heart Failure registry data to examine quality and outcomes at hospitals treating high proportions of Black patients with HF found that care is equitable, although areas for improvement remain to examine quality and outcomes at hospitals treating high proportions of Black patients with HF found that care is equitable, although areas for improvement remain. 

For the study, researchers used a comprehensive set of quality measures to examine data on clinical treatment decisions and health outcomes from nearly 500 hospitals fully participating in Get With The Guidelines - HF, an in-hospital program for improving care by promoting consistent adherence to the latest scientific treatment guidelines. They found that quality of heart failure care was equitable for 11 of 14 evidence-based clinical care measures and that there were no in-hospital disparities in care between Black and white patients. 

“These findings suggest Get With The Guidelines can help hospitals achieve equitable care for patients hospitalized with heart failure, an important American Heart Association aim,” said Gregg Fonarow, M.D., FAHA, an author of the study and an American Heart Association volunteer.  Fonarow is interim chief of the division of cardiology, director of the Ahmanson-UCLA Cardiomyopathy Center, co-director of the Preventative Cardiology Program and the Eliot Corday Chair in Cardiovascular Medicine and Science at the University of California, Los Angeles. “While there remain critical population-level disparities in access to care, social determinants of health and care quality in other settings, the Get With The Guidelines - HF program is having an important impact.” 

The study suggests inequities in HF outcomes are not only driven by gaps in care quality at hospitals, but also that there is a need for renewed focus on public health and policy efforts to target upstream factors that disproportionately affect Black adults. Researchers note that the findings have important implications for public policymakers, health system leaders and clinicians as they work toward equitable delivery of HF care. 

“For more than 20 years, Get With The Guidelines has made strides toward equitable, evidence-based care for all,” said Michelle Albert, MD, MPH, FACC, FAHA, volunteer president of the American Heart Association and the Walter A. Haas-Lucie Stern Endowed chair in cardiology and professor in medicine at the University of California at San Francisco (UCSF), admissions dean for UCSF Medical School and director of the CeNter for the Study of AdveRsiTy and CardiovascUlaR DiseasE (NURTURE Center). “This study shows the great strides we have made in heart failure care, as well as opportunities for even more improvement.” 

Co-authors are Jamie Diamond, M.D., MPH; Iyanuoluwa Ayodele, MS; Karen E. Joynt-Maddox, M.D., MPH, FAHA; Robert W. Yeh, M.D., FAHA; Gmerice Hammond, M.D., MPH; Larry A. Allen, M.D., MHS, FAHA; Stephen J. Greene, M.D.; Karen Chiswell, PhD.; Adam D. DeVore, M.D., MHS; Clyde Yancy, M.D., FAHA; Rishi K. Wadhera, M.D., MPP, MPhil. Authors’ disclosures are listed in the manuscript. 

The study was supported by an American Heart Association Get With The Guidelines - HF Young Investigator Research Seed Grant. GWTG-HF is sponsored, in part, by Novartis, Boehringer Ingelheim and Eli Lilly Diabetes Alliance, Novo Nordisk, Sanofi, AstraZeneca and Bayer. 

For more information: www.heart.org 

Related Content on New Technology and Ideas to Address Health Disparities:   

VIDEO: New Ideas in Addressing Cardiovascular Disease Disparities — Clyde Yancy, M.D   
VIDEO: How Smartphones May Revolutionize Healthcare in the Developing World —Interview with Jacques Kpodonu, M.D.   
VIDEO: Reducing Hypertension Among African-Americans — Interview with Kim Allan Williams, Sr., M.D.   
Multi-Ethnic Study of Atherosclerosis Sheds Light on Sleep Irregularity and Cardiovascular Disease 
STS Annual Meeting Session Rallies Proven Methods to Combat Racial, Gender Disparities in Heart and Lung Disease 


Related Content

News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
News | Heart Failure

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
Subscribe Now